About Fate Therapeutics, Inc.
Fate Therapeutics, Inc. interrogates stem cell biology to develop breakthrough therapeutics based on modulating cell fate and to enable a new drug discovery paradigm that includes proprietary induced-pluripotent stem (iPS) cell technology. The company's first therapeutic candidate is in clinical trials in hematopoietic reconstitution. Fate Therapeutics is a private company headquartered in San Diego, CA with a subsidiary in Ottawa, Canada. For more information, please visit www.fatetherapeutics.com.
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neuroscience, and vaccine development, as well as for its insights into autoimmune, cardiovascular, and infectious disease. Headquartered in La Jolla, California, the institute also includes a campus in Jupiter, Florida, where scientists focus on drug discovery and technology development in addition to basic biomedical science. Scripps Research currently employs about 3,000 scientists, staff, postdoctoral fellows, and graduate students on its two campuses. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, is ranked among the top ten such programs in the nation. For more information, see www.scripps.edu.
Fate Therapeutics, Inc.
Chief Financial Officer
|SOURCE Fate Therapeutics, Inc.|
Copyright©2010 PR Newswire.
All rights reserved